BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16736409)

  • 21. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
    Yoon YS; Park HS; Yun KE; Kim SB
    Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
    Vassalotti JA; Stevens LA; Levey AS
    Am J Kidney Dis; 2007 Aug; 50(2):169-80. PubMed ID: 17660017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
    Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
    Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
    Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J
    Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey.
    Farnier M; Garnier P; Yau C; Dejager S; Verpilleux MP
    Int J Clin Pract; 2006 Oct; 60(10):1166-71. PubMed ID: 16942588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular morbidity and mortality of the metabolic syndrome.
    Obunai K; Jani S; Dangas GD
    Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
    Gomez P; Ruilope LM; Barrios V; Navarro J; Prieto MA; Gonzalez O; Guerrero L; Zamorano MA; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S194-200. PubMed ID: 17130261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
    Rao MV; Qiu Y; Wang C; Bakris G
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S30-7. PubMed ID: 18359406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Clase CM; Kiberd BA; Garg AX
    Nephron Clin Pract; 2007; 105(4):c178-84. PubMed ID: 17347576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease in chronic kidney disease.
    Saran AM; DuBose TD
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and mild to moderate chronic kidney disease among minorities.
    Navaneethan SD; Schold JD; Srinivas TR
    Semin Nephrol; 2010 Jan; 30(1):51-8. PubMed ID: 20116648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the metabolic syndrome in an incident dialysis population.
    Young DO; Lund RJ; Haynatzki G; Dunlay RW
    Hemodial Int; 2007 Jan; 11(1):86-95. PubMed ID: 17257361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.